| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Noelia Granado, Sara Ares-Santos, Esther O'Shea, Carlos Vicario-Abejón, M Isabel Colado, Rosario Moratall. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine. Neurotoxicity research. vol 18. issue 1. 2010-08-31. PMID:19760475. |
this study examined the selective neuroanatomical pattern of dopaminergic neurotoxicity induced by meth in the mouse striatum. |
2010-08-31 |
2023-08-12 |
mouse |
| Noelia Granado, Sara Ares-Santos, Esther O'Shea, Carlos Vicario-Abejón, M Isabel Colado, Rosario Moratall. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine. Neurotoxicity research. vol 18. issue 1. 2010-08-31. PMID:19760475. |
the predominant loss of dopaminergic terminals in the striosomes occurred along the rostrocaudal axis of the striatum. |
2010-08-31 |
2023-08-12 |
mouse |
| Catherine A Thorn, Ann M Graybie. Pausing to regroup: thalamic gating of cortico-basal ganglia networks. Neuron. vol 67. issue 2. 2010-08-23. PMID:20670826. |
how the cholinergic and dopaminergic systems of the striatum interact and how these interface with the massive neocortical input to the striatum are classic questions of cardinal interest to neurology and psychiatry. |
2010-08-23 |
2023-08-12 |
Not clear |
| K Brinschwitz, A Dittgen, V I Madai, R Lommel, S Geisler, R W Ve. Glutamatergic axons from the lateral habenula mainly terminate on GABAergic neurons of the ventral midbrain. Neuroscience. vol 168. issue 2. 2010-08-19. PMID:20353812. |
these loops are bidirectionally controlled by the midbrain dopaminergic system, predominantly but not exclusively at the level of the striatum including the accumbens nucleus. |
2010-08-19 |
2023-08-12 |
Not clear |
| Massimo Grilli, Laura Patti, Federica Robino, Stefania Zappettini, Maurizio Raiteri, Mario March. Release-enhancing pre-synaptic muscarinic and nicotinic receptors co-exist and interact on dopaminergic nerve endings of rat nucleus accumbens. Journal of neurochemistry. vol 105. issue 6. 2010-08-13. PMID:18298664. |
dopaminergic nerve endings in the corpus striatum possess nicotinic (nachrs) and muscarinic cholinergic receptors (machrs) mediating release of dopamine (da). |
2010-08-13 |
2023-08-12 |
rat |
| Anna R Carta, Lucia Frau, Annalisa Pinna, Micaela Morell. Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression. Experimental neurology. vol 224. issue 2. 2010-07-30. PMID:20452347. |
in the dopamine-depleted striatum, an altered post-synaptic signalling of efferent neurons might underline the onset of variable dyskinetic responses to dopaminergic agonists. |
2010-07-30 |
2023-08-12 |
rat |
| E A Kozina, V G Khaindrava, V S Kudrin, V G Kucherianu, P D Klodt, E V Bocharov, K S Raevskiĭ, G N Kryzhanovskiĭ, M V Ugriumo. [Experimental modeling of functional deficiency of the nigrostriatal dopaminergic system in mice]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. vol 96. issue 3. 2010-07-20. PMID:20535997. |
cell bodies of dopaminergic da-ergic neurons are located in the compact zone of the substantia nigra, and their axons are projected along the nigrostriatal tract to the striatum. |
2010-07-20 |
2023-08-12 |
mouse |
| Birgit Mertens, Patrick Vanderheyden, Yvette Michotte, Sophie Sarr. Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum. Neuropharmacology. vol 58. issue 7. 2010-07-19. PMID:20097214. |
a relationship between the central renin angiotensin system and the dopaminergic system has been described in the striatum. |
2010-07-19 |
2023-08-12 |
rat |
| Piotr Hadaczek, Louisa Johnston, John Forsayeth, Krystof S Bankiewic. Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain. Neuropharmacology. vol 58. issue 7. 2010-07-19. PMID:20153340. |
convection-enhanced delivery (ced) of gdnf and ntn was employed to determine the tissue clearance of these factors from the rat striatum and the response of the dopaminergic system to a single infusion. |
2010-07-19 |
2023-08-12 |
rat |
| Simon Cervenka, Andrea Varrone, Erik Fransén, Christer Halldin, Lars Fard. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans. Synapse (New York, N.Y.). vol 64. issue 6. 2010-07-19. PMID:20175222. |
most molecular imaging studies of the dopamine (da) system performed to date have focused on the striatum, a region receiving dense dopaminergic innervation. |
2010-07-19 |
2023-08-12 |
human |
| Yuexiang Wang, Keith F Moquin, Adrian C Michae. Evidence for coupling between steady-state and dynamic extracellular dopamine concentrations in the rat striatum. Journal of neurochemistry. vol 114. issue 1. 2010-07-19. PMID:20403079. |
a previous study from our laboratory demonstrated the presence within the rat striatum of dopaminergic terminals in different dynamical states, determined at least in part by the extent to which terminals are subject to autoinhibition. |
2010-07-19 |
2023-08-12 |
human |
| Béchir Jarraya, Sabrina Boulet, G Scott Ralph, Caroline Jan, Gilles Bonvento, Mimoun Azzouz, James E Miskin, Masahiro Shin, Thierry Delzescaux, Xavier Drouot, Anne-Sophie Hérard, Denise M Day, Emmanuel Brouillet, Susan M Kingsman, Philippe Hantraye, Kyriacos A Mitrophanous, Nicholas D Mazarakis, Stéphane Palf. Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. Science translational medicine. vol 1. issue 2. 2010-07-12. PMID:20368163. |
the standard treatment is administration of pharmacological agents that transiently increase concentrations of brain dopamine and thereby discontinuously modulate neuronal activity in the striatum, the primary target of dopaminergic neurons. |
2010-07-12 |
2023-08-12 |
monkey |
| Kevin J Skoblenick, Niran Argintaru, Yingtao Xu, Bailee A Dyck, Dipannita Basu, Mattea L Tan, Michael F Mazurek, Ram K Mishr. Role of AP-2alpha transcription factor in the regulation of synapsin II gene expression by dopamine D1 and D2 receptors. Journal of molecular neuroscience : MN. vol 41. issue 2. 2010-07-09. PMID:19842069. |
previous studies have reported an increase in synapsin ii protein by dopaminergic agents in the striatum, medial prefrontal cortex, and nucleus accumbens. |
2010-07-09 |
2023-08-12 |
Not clear |
| Hyo Geun Kim, Mi Sun Ju, Jin Sup Shim, Min Cheol Kim, Sang-Hun Lee, Youngbuhm Huh, Sun Yeou Kim, Myung Sook O. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models. The British journal of nutrition. vol 104. issue 1. 2010-07-09. PMID:20187987. |
parkinson's disease (pd), one of the most common neurodegenerative disorders, is characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta (snpc) to the striatum (st), and involves oxidative stress. |
2010-07-09 |
2023-08-12 |
mouse |
| Konstantinos Botsakis, Ourania Pavlou, Paraskevi D Poulou, Nikolaos Matsokis, Fevronia Angelato. Blockade of adenosine A2A receptors downregulates DARPP-32 but increases ERK1/2 activity in striatum of dopamine deficient "weaver" mouse. Neurochemistry international. vol 56. issue 2. 2010-07-08. PMID:19852993. |
our results revealed that the endogenous levels of phospho-darppp-32 and phospho-erk1/2 are elevated in "weaver" striatum probably as an adaptation phenomenon to gradual dopaminergic neurodegeneration appearing in this animal model, characterized as phenocopy of parkinson's disease. |
2010-07-08 |
2023-08-12 |
mouse |
| Garret D Stuber, Thomas S Hnasko, Jonathan P Britt, Robert H Edwards, Antonello Bonc. Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 24. 2010-07-02. PMID:20554874. |
here, we expressed the light-activated cation channel channelrhodopsin-2 (chr2) in genetically defined midbrain dopamine neurons to stimulate exocytosis specifically from dopaminergic terminals in both the nucleus accumbens (nac) shell and dorsal striatum of brain slices from adult mice. |
2010-07-02 |
2023-08-12 |
mouse |
| Chih W Hsu, Chin S Wang, Ted H Chi. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice. Journal of biomedical science. vol 17. 2010-06-29. PMID:20074377. |
since these behavioral and therapeutic effects are mediated by the mesolimbic and nigrostriatal dopaminergic pathways which project to the striatum, we hypothesize that low doses of caffeine and sch58261 may modulate the functions of dopaminergic neurons in the striatum. |
2010-06-29 |
2023-08-12 |
mouse |
| Michael J O'Neill, Eric R Siemer. Pharmacological approaches to disease-modifying therapies in Parkinson's disease. Expert review of neurotherapeutics. vol 2. issue 6. 2010-06-28. PMID:19810916. |
dopaminergic cells located in the substantia nigra and whose terminals extend to the striatum degenerate slowly such that 60% of cells are already lost when clinical motor symptoms first become evident. |
2010-06-28 |
2023-08-12 |
Not clear |
| Mark Slifstein, Lawrence S Kegeles, Xiaoyan Xu, Judy L Thompson, Nina Urban, John Castrillon, Elizabeth Hackett, S-A Bae, Marc Laruelle, Anissa Abi-Dargha. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse (New York, N.Y.). vol 64. issue 5. 2010-06-23. PMID:20029833. |
the amphetamine challenge, in which positron emission tomography (pet) or single photon emission computed tomography radioligand binding following administration of amphetamine is compared to baseline values, has been successfully used in a number of brain imaging studies as an indicator of dopaminergic function, particularly in the striatum. |
2010-06-23 |
2023-08-12 |
human |
| Sylvia Navailles, Bernard Bioulac, Christian Gross, Philippe De Deurwaerdèr. Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease. Neurobiology of disease. vol 38. issue 1. 2010-06-22. PMID:20096781. |
however, the putative involvement of serotonergic neurons in the dopaminergic effects of l-dopa suggests that the striatum is not a preferential target of l-dopa. |
2010-06-22 |
2023-08-12 |
rat |